SI1474174T1 - Sestavek za oralno ali rektalno dajanje - Google Patents

Sestavek za oralno ali rektalno dajanje

Info

Publication number
SI1474174T1
SI1474174T1 SI200331606T SI200331606T SI1474174T1 SI 1474174 T1 SI1474174 T1 SI 1474174T1 SI 200331606 T SI200331606 T SI 200331606T SI 200331606 T SI200331606 T SI 200331606T SI 1474174 T1 SI1474174 T1 SI 1474174T1
Authority
SI
Slovenia
Prior art keywords
composition
suppository
tablet
oral
food supplement
Prior art date
Application number
SI200331606T
Other languages
English (en)
Inventor
Bengt Herslof
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of SI1474174T1 publication Critical patent/SI1474174T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
SI200331606T 2002-02-15 2003-02-14 Sestavek za oralno ali rektalno dajanje SI1474174T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200475A SE0200475D0 (sv) 2002-02-15 2002-02-15 Oral farmaceutisk beredning
PCT/SE2003/000251 WO2003068267A1 (en) 2002-02-15 2003-02-14 Composition for oral or rectal administration
EP03703650A EP1474174B1 (en) 2002-02-15 2003-02-14 Composition for oral or rectal administration

Publications (1)

Publication Number Publication Date
SI1474174T1 true SI1474174T1 (sl) 2009-08-31

Family

ID=20286999

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331606T SI1474174T1 (sl) 2002-02-15 2003-02-14 Sestavek za oralno ali rektalno dajanje

Country Status (20)

Country Link
US (1) US20050181042A1 (sl)
EP (1) EP1474174B1 (sl)
JP (1) JP2005520816A (sl)
KR (1) KR20040089633A (sl)
CN (1) CN101060862A (sl)
AT (1) ATE430585T1 (sl)
AU (1) AU2003206355B2 (sl)
BR (1) BR0313651A2 (sl)
CA (1) CA2475025C (sl)
DE (1) DE60327511D1 (sl)
DK (1) DK1474174T3 (sl)
ES (1) ES2324603T3 (sl)
MX (1) MXPA04007946A (sl)
NZ (1) NZ534812A (sl)
PT (1) PT1474174E (sl)
RU (1) RU2302260C2 (sl)
SE (1) SE0200475D0 (sl)
SI (1) SI1474174T1 (sl)
WO (1) WO2003068267A1 (sl)
ZA (1) ZA200406399B (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
SE0400233D0 (sv) * 2004-02-04 2004-02-04 Ltp Lipid Technologies Provide Rektal komposition
EA012882B1 (ru) * 2005-04-28 2009-12-30 ДСМ АйПи ЭССЕТС Б.В. Фармацевтические лекарственные формы, содержащие липидную фазу
WO2007098446A2 (en) * 2006-02-21 2007-08-30 Accu-Break Pharmaceuticals, Inc. Method for minimizing variation in dosage forms
CN101278928B (zh) 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 含左卡尼汀或其衍生物的药物组合物及其用途
CN101991557B (zh) * 2009-08-10 2013-09-18 杭州赛利药物研究所有限公司 一种盐酸万古霉素液体胶囊及其制备方法
US20140044779A1 (en) * 2011-04-18 2014-02-13 Lipidor Ab Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent
US10117885B2 (en) * 2011-08-11 2018-11-06 Allergy Research Group, Llc Chewable lipid supplements for treating pain and fibromyalgia
CN102631290A (zh) * 2012-04-05 2012-08-15 韩昌志 一种生产栓剂的综合法
US10456327B2 (en) 2015-08-28 2019-10-29 Craig Robertson Package for frozen nutrient pill

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7812466A (nl) * 1978-12-22 1980-06-24 Shell Int Research Werkwijze voor de bereiding van gasmengsels.
DE2951142C2 (de) * 1979-12-19 1983-11-03 A. Nattermann & Cie GmbH, 5000 Köln Suppositorium-Zubereitung von Indometacin oder Acemetacin
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
US5505982A (en) * 1994-01-28 1996-04-09 Fmc Corporation Chocolate confection
KR100220546B1 (ko) * 1994-02-04 1999-09-15 벵 헤르슬로프 호지성 담체 제제
JP2948111B2 (ja) * 1994-09-16 1999-09-13 塩野義製薬株式会社 経口投与用油性組成物
DE29511421U1 (de) * 1995-07-14 1995-10-12 Chou, Wen San, An Ting, Tainan Luftkompressor
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
ID21009A (id) * 1997-10-08 1999-04-08 Taisho Pharmaceutical Co Ltd Komposisi untuk supositori
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
EP1043016B1 (en) * 1999-03-30 2014-08-20 Sodic Sa A plant extract based on glycerides,phospholipids and phytosphingolipids, a method for the preparation of this extract and a cosmetic composition containing the same
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
KR100602299B1 (ko) * 2000-12-14 2006-07-14 에프. 호프만-라 로슈 아게 자가 유화성 지질 매트릭스

Also Published As

Publication number Publication date
WO2003068267A1 (en) 2003-08-21
ZA200406399B (en) 2005-09-12
RU2004124042A (ru) 2005-06-10
PT1474174E (pt) 2009-06-25
AU2003206355A1 (en) 2003-09-04
DK1474174T3 (da) 2009-07-06
CA2475025C (en) 2010-07-27
BR0313651A2 (pt) 2008-11-11
CN101060862A (zh) 2007-10-24
NZ534812A (en) 2006-10-27
ATE430585T1 (de) 2009-05-15
JP2005520816A (ja) 2005-07-14
SE0200475D0 (sv) 2002-02-15
KR20040089633A (ko) 2004-10-21
CA2475025A1 (en) 2003-08-21
EP1474174B1 (en) 2009-05-06
ES2324603T3 (es) 2009-08-11
US20050181042A1 (en) 2005-08-18
DE60327511D1 (de) 2009-06-18
MXPA04007946A (es) 2005-06-08
RU2302260C2 (ru) 2007-07-10
AU2003206355B2 (en) 2007-03-01
EP1474174A1 (en) 2004-11-10

Similar Documents

Publication Publication Date Title
BR0312427A (pt) Combinação, uso de uma combinação, método para a produção de um efeito inibitório de ibat em um animal de sangue quente, método de prevenção de diarréia, composição farmacêutica, método de tratamento de condições hiperlipidêmicas em um animal de sangue quente, e, uso de um sal metálico
ATE228015T1 (de) Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden
NZ514574A (en) Novel method of treatment
MXPA01008058A (es) Composiciones deinhibidor de cicloxigenasa-2 teniendo un rapido inicio de efecto terapeutico.
MY127126A (en) Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
CA2229624A1 (en) Method of reducing bodyweight and treating obesity
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
IL158899A0 (en) Pharmaceutical compositions for inhibiting angiogenesis containing oleuropein and derivatives thereof
GEP20063783B (en) N-Phenpropylcyclopentyl-Substituted Glutaramide Derivatives as Inhibitors of Neutral Endopeptidase Enzyme (NEP) for Treating Female Sexual Dysfunction (FSAD)
HUP0101268A2 (hu) A női nemi diszfunkció kezelésére alkalmas gyógyszerkészítmények
HK1057899A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
PT1474174E (pt) Composição para administração oral ou rectal
EE05423B1 (et) IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
MY128366A (en) Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
WO1995031991A3 (en) Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
EP1178796A4 (en) AMINOIMIDAZOLE CARBOXAMIDE SALTS USEFUL IN THE PREVENTION AND TREATMENT OF LIVER DISEASE
MY140954A (en) Composition for oral or rectal administration
PL324012A1 (en) N-hydroxyureas as antiinflammatory agents
EP1123692A3 (fr) Utilisation de dérivés de polyaminoacides pour traiter la séborrhée et les désordres cutanés associés
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
MA28224A1 (fr) Nitro-oxyderives de medicaments contre l'hypertension.